PMID- 20007378 OWN - NLM STAT- MEDLINE DCOM- 20100218 LR - 20211020 IS - 1091-6490 (Electronic) IS - 0027-8424 (Print) IS - 0027-8424 (Linking) VI - 106 IP - 51 DP - 2009 Dec 22 TI - Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3. PG - 21608-13 LID - 10.1073/pnas.0912101106 [doi] AB - The kinase domain of human epidermal growth factor receptor (HER) 3/ErbB3, a member of the EGF receptor (EGFR) family, lacks several residues that are critical for catalysis. Because catalytic activity in EGFR family members is switched on by an allosteric interaction between kinase domains in an asymmetric kinase domain dimer, HER3 might be specialized to serve as an activator of other EGFR family members. We have determined the crystal structure of the HER3 kinase domain and show that it appears to be locked into an inactive conformation that resembles that of EGFR and HER4. Although the crystal structure shows that the HER3 kinase domain binds ATP, we confirm that it is catalytically inactive but can serve as an activator of the EGFR kinase domain. The HER3 kinase domain forms a dimer in the crystal, mediated by hydrophobic contacts between the N-terminal lobes of the kinase domains. This N-lobe dimer closely resembles a dimer formed by inactive HER4 kinase domains in crystal structures determined previously, and molecular dynamics simulations suggest that the HER3 and HER4 N-lobe dimers are stable. The kinase domains of HER3 and HER4 form similar chains in their respective crystal lattices, in which N-lobe dimers are linked together by reciprocal exchange of C-terminal tails. The conservation of this tiling pattern in HER3 and HER4, which is the closest evolutionary homolog of HER3, might represent a general mechanism by which this branch of the HER receptors restricts ligand-independent formation of active heterodimers with other members of the EGFR family. FAU - Jura, Natalia AU - Jura N AD - Department of Molecular and Cell Biology, California Institute for Quantitative Biosciences, University of California, Berkeley, CA 94720, USA. FAU - Shan, Yibing AU - Shan Y FAU - Cao, Xiaoxian AU - Cao X FAU - Shaw, David E AU - Shaw DE FAU - Kuriyan, John AU - Kuriyan J LA - eng SI - PDB/3KEX GR - R01 CA096504/CA/NCI NIH HHS/United States GR - R01 CA96504-06/CA/NCI NIH HHS/United States GR - HHMI/Howard Hughes Medical Institute/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. DEP - 20091209 PL - United States TA - Proc Natl Acad Sci U S A JT - Proceedings of the National Academy of Sciences of the United States of America JID - 7505876 RN - EC 2.7.10.1 (ErbB Receptors) SB - IM MH - Allosteric Regulation MH - Amino Acid Sequence MH - Biocatalysis MH - Crystallography, X-Ray MH - Dimerization MH - ErbB Receptors/*chemistry/metabolism MH - Humans MH - Models, Molecular MH - Molecular Dynamics Simulation MH - Molecular Sequence Data MH - Protein Conformation MH - Sequence Homology, Amino Acid PMC - PMC2791034 COIS- The authors declare no conflict of interest. EDAT- 2009/12/17 06:00 MHDA- 2010/02/19 06:00 PMCR- 2009/12/09 CRDT- 2009/12/17 06:00 PHST- 2009/12/17 06:00 [entrez] PHST- 2009/12/17 06:00 [pubmed] PHST- 2010/02/19 06:00 [medline] PHST- 2009/12/09 00:00 [pmc-release] AID - 0912101106 [pii] AID - 0692 [pii] AID - 10.1073/pnas.0912101106 [doi] PST - ppublish SO - Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21608-13. doi: 10.1073/pnas.0912101106. Epub 2009 Dec 9.